Cardiorespiratory fitness (CRF) is a key predictor of chronic disease, particularly cardiovascular disease (CVD), but its assessment usually requires exercise testing which is impractical and costly in most health-care settings. Nonexercise testing cardiorespiratory fitness (NET-F)-estimating methods are a less resource-demanding alternative, but their predictive capacity for CVD and total mortality has yet to be tested. The objective of this study is to examine the association of a validated NET-F algorithm with all-cause and CVD mortality.
Introduction
Cardiorespiratory fitness (CRF) is a measure of the capacity of the cardiovascular system to transport oxygen and the ability of the muscles to use it. 1 Low CRF has repeatedly been shown to predict increased cardiovascular disease (CVD) risk independently of conventional risk factors such as hypertension, hyperlipidaemia, obesity, and smoking. 2 -8 Furthermore, CRF estimated through exercise testing has been shown to significantly improve classification of both short-and long-term risk for CVD mortality when added to traditional risk factors, such as age, systolic blood pressure, diabetes mellitus, total cholesterol, and smoking. 9 However, unlike conventional risk factors, CRF is not currently a routinely assessed component of individual risk assessment in primary care. This may be due to practical issues because the measurement of CRF, even by submaximal exercise test (e.g. indirect calorimetry during a graded exercise test), requires trained staff and the use of specialist exercise equipment and is time-consuming. Submaximal exercise tests without the measurement of gas exchange are also burdening for the patient and require the use of specialized equipment such as bicycle ergometers or treadmills that are rarely available in health-care settings. Dynamic tests without equipment, such as bleep tests 10 and the 6 min walk test, 11 are more feasible but nevertheless require supervised exercise for the patient. 12 An international group of experts, by expanding on previous developmental and evaluation work in this area of research, 13 have developed a non-exercise testing cardiorespiratory fitness (NET-F) assessment method.
14 It is inherently a cost-effective method and highly feasible because all variables proposed for the estimation of NET-F are either routinely available [gender, age, body mass index (BMI), resting pulse rate] or relatively easy to obtain (self-reported physical activity) in a primary care setting. While the new NET-F-estimating method has been shown to have good concurrent validity against exercise testing-estimated CRF, 14, 15 crucially, its predictive ability for outcomes that have previously been shown to be linked to CRF (all-cause and CVD mortality) has yet to be tested. The aim of the present analyses is to examine the associations between NET-F with CVD and all-cause mortality and to assess the extent to which any association is independent of the constituent components of NET-F, BMI, resting heart rate, and selfreported physical activity.
Methods

Study sample and design
Details of the sample design and selection can be found elsewhere. 16, 17 In brief, participants were drawn from the Health Survey for England (HSE) and the Scottish Health Survey (SHS)-a series of independent cohort studies with baseline examinations in 1994 (HSE only), 1995 (SHS only), 1998, 1999 (HSE only), 2003, and 2004 (HSE only). The two surveys are run by the same research agencies (Joint Health Surveys Unit) and have identical methodologies. The two studies are general population-based, sampling individuals living in households in each country. HSE and SHS samples were selected using a multistage, stratified, probability design to give a representative sample of the target populations. Stratification was based on geographical areas and not on individual characteristics: postcode (zip code) sectors were selected at the first stage and household addresses selected at the second stage. Ethical approval had been granted for all aspects of these studies by the Local Research Ethics Councils prior to each survey year data collection.
Participants in this study were aged 35 -70 years at study induction. In the present analyses, we included cohort members with complete data on NET-F and conventional risk factors, and those who were free of doctor-diagnosed CVD [coronary heart disease (CHD), stroke, angina] at baseline. Seventy years was chosen as the upper age limit because the NET-F method 14 was developed using a 20-to 70-year old sample. 18 
Clinical characteristics
Height and weight were measured by trained interviewers using standard protocols. 16, 17 Computer-assisted personal interviewing modules assessed respondents' demographics, health status and history of disease, and health behaviours. Psychological health was evaluated using the General Health Questionnaire 12 (GHQ, 12-item version). 19, 20 In a separate visit, qualified nurses collected information on prescribed medication and measured respondent's resting heart rate (RHR) three times following 5 min of seated rest using an Omron 907 monitor (Omron Corporation, Japan). The RHR was computed as the average of the second and third reading. Cardiovascular medication was defined using the British National Formulary 21 classification and it included positive inotropic drugs, anti-arrhythmics, diuretics, b-blockers, angiotensin-converting enzyme-inhibitors, calcium-channel blockers, nitrates, anticoagulants, antiplatelets, and lipid-regulating drugs. Physical activity questions 22, 23 included the frequency (number of days in the last 4 weeks) and duration (minutes per day) of participation in domestic activity (e.g. housework, DIY, gardening, restoration work), brisk walking and cycling for any purpose, and any recreational exercise of moderate-to-vigorous intensity 24 (e.g. swimming, aerobics, callisthenics, gym exercises, team sports, racket sports). The criterion validity of the physical activity questionnaire has been demonstrated in a study on 106 English adults from the general population (45 men) where the output of accelerometers (worn for two non-consecutive weeks over a month period) was compared with responses to these questions. 25 
Non-exercise testing cardiorespiratory fitness
Non-exercise testing cardiorespiratory fitness estimates were converted into maximal aerobic capacity metabolic equivalent (MET) values such that one MET corresponded to an oxygen consumption of 3.5 mL/kg/min (based on a 70 kg man aged 40 years). 26 Out of the three NET-F algorithms developed originally, 14 we selected the algorithm that was developed in a UK population (the National Fitness Survey ). The criteria for this selection were both pragmatic (similarity of the National Fitness Survey and HSE/SHS populations) and statistical [in preliminary receiver operating characteristic (ROC) analyses, we found the best predictive ability for this algorithm against mortality]. The algorithm was calculated as follows: 
Mortality follow-up
Participants were flagged by the British National Health Service (NHS) Central Registry, who notified us of the date and cause of death where applicable. Diagnoses for the primary cause of death was based on the International Classification of Diseases, Ninth (ICD-9) and Tenth (ICD-10) Revisions. Codes corresponding to CVD mortality were 390-459 for ICD-9 and I01-I99 for ICD-10.
Data handling and statistical analysis
Due to marked sex differences in NET-F levels, all results were presented for men and women separately. Study participants' characteristics are presented by NET-F quartiles, and differences across quartiles were tested using x 2 tests (categorical variables) or one-way analysis of variance (continuous variables). We calculated age-standardized absolute risk rates (per 10 000 participants) for all-cause and CVD mortality by NET-F quartiles. With no major violation of the proportional hazards assumption evident, the Cox regression model was used, with months as the time scale, to estimate the risk of mortality according to the NET-F category. Surviving participants were censored at 31 December 2008 (SHS cohorts) or 15 February 2008 (HSE cohorts). Hazard ratios were computed as per SD increase in NET-F. All Cox models were adjusted for age, social class (based on the Registrar General's social occupational classification 27 which is grouped as follows:
professional, managerial and technical, skilled non-manual, skilled manual, partly-skilled, unskilled/routine occupations), smoking (light smoker, heavy smoker, ex-smoker, non-smoker), anti-hypertensive and other cardiovascular medication, GHQ12 score, doctor-diagnosed diabetes, and long-standing illness when appropriate. Sensitivity analyses excluded participants who died during the first 36 months of follow-up to reduce the likelihood of reverse causation. To compare the relative predictive value of NET-F and each of its modifiable constituent components (BMI, resting heart rate, physical activity), we constructed ROC curves with corresponding areas under the curve (AUC). The AUC (also known as c-statistic) is equal to the probability that a classifier will rank a randomly chosen positive instance higher than a randomly chosen negative one (0.50 ¼ risk prediction by pure chance) and 95% confidence intervals (CIs) separately for allcause and CVD mortality. To compare the relative discriminant ability of the NET-F and the aggregate of its modifiable constituent components (BMI, RHR, MVPA), we used existing methods 28 to develop a continuous clustered score. After z-score conversion [z ¼ (value 2 mean)/standard deviation (SD)] of these three constituent component variables, the three z scores were summed and the sum was divided by 3 to compile this score with units of SD. For MVPA (which is protective for mortality risk), the z scores were multiplied by 21.
Using standard methods, 29 we further assessed discrimination by calculating the proportion of all-cause and CVD deaths that occurred in the bottom quintile of the NET-F score (i.e. sensitivity of the highest risk quintile of predicted risk for identifying deaths) and the proportion of individuals without events who are not in the bottom quintile of the test (i.e. specificity of the highest risk quintile for deaths). To assess calibration, we calculated modelpredicted risk of all-cause and CVD mortality for each NET-F quintile and compared these values to observed mortality risk per quintile. For the observed risk, we used the Kaplan-Meier-derived mean cumulative hazard functions. For the predicted risk, we used the calculated mean cumulative hazard function from the (fully-adjusted) Cox models. We compared the net reclassification for CVD mortality risk between tertiles of the NET-F algorithm and tertiles of the aggregate standardized (but unweighted) score of the modifiable NET-F components we described above. 30 We calculated the net reclassification improvement (NRI) for using a previously described formula 31 :
where P is the proportion of participants moving up or down in terms of predicted risk category. All analyses were performed using SPSS version 17 (IBM Inc.) and all tests of statistical significance were based on two-sided probability (P , 0.05).
Results
Out of the 59 401 participants (26 595 men) aged 35-70 years who were initially considered, 7214 (12.1%) did not consent to their record being linked to mortality data or were lost to followup; 3810 reported doctor-diagnosed CVD and were excluded. Among the remaining 48 542 participants, NET-F for 14 591 could not be calculated owing to missing data for resting heart rate (n ¼ Associations between a non-exercise testing method for estimating CRF and mortality with those included, the excluded from the analysis sample were slightly older (51.9 vs. 50. There was a total of 288 988 person-years at risk for the 9.0 (+3.6) years of average follow-up. A total of 2165 deaths (1194 among men) occurred during the follow-up, of which 460 were due to CVD causes (277 among men). Table 1 presents the characteristics of the sample by the NET-F quartile. In both men and women, NET-F was inversely associated with age, smoking, (manual) social class, doctor-diagnosed hypertension and diabetes, anti-hypertensive and other cardiovascular medication, long standing illness, BMI, and resting heart rate, and directly associated with MVPA. The mean NET-F was 10.9 (+1.6) for men and 8.0 (+1.7) for women. Supplementary material online, Figure S1 , presents the distribution of NET-F values in men and women. There was a clear gradient in age-standardized absolute risk for any cause and CVD death among both men Moderate-to-vigorous physical activity c This score includes measures of BMI, resting heart rate, and moderate-to-vigorous physical activity. After z-score conversion [z ¼ (value 2 mean)/SD], the three z-scores were summed and the sum was divided by 3 to compile a score with units of SD. For moderate-to-vigorous physical activity (which is protective for mortality risk), the z-score was multiplied by 21. a NET-F is a weighted score computed using BMI, resting heart rate, moderate-to-vigorous physical activity, age, and sex. and women (see Supplementary material online, Figures S2 and S3 ). Higher NET-F was associated with lower all-cause mortality among both men and women ( Table 2) . Although these associations were attenuated following adjustments for potential confounders, they did remain statistically significant. There was also an association between higher NET-F and lower CVD mortality which persisted following adjustments for potential confounders ( Table 3) . In general, the Cox model hazard ratios per SD increase in NET-F were lower for men than for women. Excluding deaths from any cause (or CVD deaths) occurring in the first 36 months of followup did not appreciably change the results (see Supplementary material online, Table S1 ). Table 4 presents the discrimination statistics for NET-F for allcause and CVD mortality. The AUC for all-cause mortality was comparable between men [e.g. the c-statistic ¼ 0.73 (95% CI: 0.71-0.74)] and women [0.70 (0.68-0.71)], and the same was true for CVD mortality as an outcome. Non-exercise testing cardiorespiratory fitness (Table 4 ) demonstrated appreciably greater discriminative ability (based on the AUC) than any single component variable or the aggregate score of its modifiable constituent components ( Table 5 ). The sensitivity of the NET-F algorithm to predict events occurring in the highest risk quintile was better for CVD (0.49 in both sexes) than all-cause mortality (0.44 and 0.40 for men and women, respectively). The specificity was comparable across all gender by outcome groups (range: 0.80-0.82). Figures 1 and 2 show the mean predicted vs. observed risk for all-cause and CVD mortality, respectively, by fifths of NET-F. For both men and women, the all-cause mortality plots show a tendency for over-prediction for those participants in the lowest NET-F quintiles. The CVD mortality plots showed fair calibration for both men and women, although there is a tendency to overpredict CVD deaths among participants in the lowest NET-F quintiles. Table 6 presents the reclassification statistics for CVD mortality. Compared with the aggregate score of its potentially modifiable constituent components, NET-F reclassified risk correctly (i.e. to a category of higher risk) 25.6% of men and 20.2% of women who had a fatal CVD event. The overall NRI was excellent at 27.2% for men and 21.0% for women (both P , 0.001).
Discussion
To our knowledge, this is the first study to examine the associations of the NET-F-estimating method with mortality and one of the few to study non-exercise testing-estimated fitness in general. In this population sample of 35-to 70-year olds, NET-F was consistently associated with all-cause and CVD mortality with minor gender differences. The reductions in mortality risk associated with increased NET-F are comparable to those reported in other studies that looked at the associations between exercise testing-estimated CRF and mortality. For example, a meta-analysis of 33 studies ( 85 000 individuals) 26 found that the relative risk reduction associated with 1 MET increase in CRF was 13% (95% CI: 10-16%) for all-cause mortality and 15% (12 -18%) for CVD events. In our study, a 1 SD increase in NET-F (corresponding to 1.6 -1.7 MET) was associated with a 15% (7-22%) and a 12% (2-20%) decrease in risk for death Figure 1 Calibration by quintile of non-exercise testing cardiorespiratory fitness (a weighted score computed using BMI, resting heart rate, physical activity, age, and sex) score for men (A) and women (B) for all-cause mortality risk. The observed values correspond to the Kaplan-Meier cumulative hazard; predicted values correspond to the Cox model-derived cumulative hazard. Figure 2 Calibration by quintile of non-exercise testing cardiorespiratory fitness (a weighted score computed using BMI, resting heart rate, physical activity, age, and sex) score for men (A) and women (B) for cardiovascular disease mortality risk. The observed values correspond to the Kaplan-Meier cumulative hazard; predicted values correspond to the Cox model-derived cumulative hazard.
Associations between a non-exercise testing method for estimating CRF and mortality from any cause and a 25% (10-33%) and a 27% (8-40%) decrease in risk for CVD death in men and women, respectively.
Studies looking at the associations between other non-exercise CRF estimates and mortality are scarce. The Women's Ischemia Syndrome Evaluation (WISE) study 32 evaluated CRF using a selfreported measurement that assessed the ability to perform various activities; this measurement had previously been found to correlate with exercise testing-estimated CRF. 33 Each 1-MET increase in estimated CRF was associated with an 8% (11-15%) decrease in risk of major CVD events among 1000 women during the average 4-year follow-up. 32 Although this level of relative risk reduction is considerably lower than that conferred by our NET-F measurement, the WISE study results also support the potential of non-exercise CRF estimation methods for CVD death risk prediction at a population level. In another study of 858 men followed up over 16.5 years, self-rated fitness was at least as good a predictor of mortality as self-reported health, and men reporting poor fitness were at three times the elevated risk of death. 34 We found that NET-F had considerably higher predictive ability compared with any of its modifiable constituent components alone or their standardized aggregate score (as judged by the c-statistic). This suggests that NET-F is a superior risk prediction method when compared with RHR, physical activity, or BMI alone or jointly in terms of both all-cause and CVD-specific mortality. The excellent NRI that NET-F demonstrated (.27% for men and 21% for women), which was mainly due to considerable improvements in the classification of the CVD cases, provides further evidence on the superiority of NET-F over its unweighted modifiable components in terms of CVD death risk prediction. It is noteworthy that the discriminative ability of NET-F (c-statistic for CVD death: 0.73-0.75) is comparable to the c-statistics of 0.74-0.77 for the Framingham risk prediction model, 35 a score which is used worldwide to make decisions about preventive interventions, such as lipid-lowering treatment, lifestyle intervention recommendations, and aspirin use. 36, 37 Overall, these findings suggest that NET-F estimates are robust predictors of overall and CVD-specific mortality, and may be considered for incorporation into the medical examination routine of physicians and preventive cardiologists. Although this study supports the predictive value of NET-F at a population level, it does not give any information on the utility of a This score includes measures of BMI, resting heart rate, and moderate-to-vigorous physical activity. After z-score conversion [z ¼ (value 2 mean)/SD], the three z scores were summed and the sum was divided by 3 to compile a score with units of SD. For moderate-to-vigorous physical activity (which is protective for mortality risk), the z scores were multiplied by 21.
b NET-F is a weighted score computed using BMI, resting heart rate, physical activity, age, and sex. c Calculated as NRI ¼ [P(up|event) 2 P(down|event) + P(down|non-event) 2 P(up|non-event)] × 100, where P is the proportion of participants moving up or down in terms of the predicted risk category.
the method as a means of assessment of CRF changes during fitness programmes. Further, it does not give information on the classification agreement between NET-F and actual (measured) CRF or exercise testing-estimated CRF. Furthermore, it remains unknown whether changes in intervention-induced improvements in NET-F will be translated into improvements in the outcomes (e.g. CHD events). These are questions that can optimally be answered using controlled trial designs, although such studies would require large sample sizes and relatively long follow-up.
The key strengths of our study included the large population sample and number of events that allowed us to take generous measures to reduce the chances of reverse causation (e.g. exclude deaths occurring in the first 3 years of follow-up), and the availability of a broad range of potential confounders that we took into account in our multivariable models. There are also some caveats to the findings reported here. Our analyses are based on a cohort comprising mainly white Europeans so it is unknown if the results are generalizable to other ethnic groups. We were unable to consider changes in NET-F over time as there was only one baseline measurement of the variables required for the computation of the algorithm. Like the conventional exercise testing-based methods, NET-F cannot capture the genetic component of CRF. Our analyses are limited to fatal CVD events because we had only mortality as an outcome for the whole data set. The participants excluded from our study due to missing data might have introduced bias into the analyses. Lastly, the most heavily weighted variable (physical activity) was the only component of the algorithm that was assessed using subjective methods (self-reports), which might have introduced bias and noise into the results. Perhaps, an NET-F method containing an objectively assessed physical activity component (measured by e.g. pedometers or accelerometers) would have been an even more powerful predictor of mortality but it is unlikely that such assessments are feasible and practical in most clinical settings.
In conclusion, our findings from a large population-based study suggest that the NET-F-estimating method may be a useful novel tool to predict cardiovascular and overall mortality in adults. Further research is needed to examine the feasibility, costeffectiveness, and incremental predictive value of this test in routine clinical practice.
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